Proteomic Characterization of Changes in Mouse Brain Cortex Protein Expression at Different Post-Mortem Intervals: A
Martina Bonelli1,2, Fabrizio Di Giuseppe2,3, Nicola Tupone2,3
1Department of Medicine and Aging Sciences, University "G. d'Annunzio" of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy.
International Journal of Molecular Sciences
|August 29, 2024
Summary
Accurate post-mortem interval (PMI) estimation relies on understanding tissue degradation. This study identified specific proteins, like Calpain11 and Caspases, as potential biomarkers for determining PMI with improved accuracy.
Area of Science:
- Forensic Science
- Biomarker Discovery
- Proteomics
Background:
- Accurate post-mortem interval (PMI) estimation is crucial for thanato-chronological purposes.
- Tissue degradation and precise PMI determination depend heavily on biological sample condition.
- Optimizing tissue handling and identifying sensitive post-mortem biomarkers can establish timelines for post-mortem events.
Purpose of the Study:
- To investigate proteome changes in mouse brain cortex samples over a post-mortem time course.
- To identify potential protein biomarkers indicative of different post-mortem intervals (PMIs).
Main Methods:
- Proteomic analysis of mouse cortex samples collected at various post-mortem time points (0, 4, 8, 12, 24, 32 hours) after cold storage (4 °C).
- Analysis focused on early (<24 h) and late (>24 h) PMIs compared to time-zero (T0) samples.
- Validation using LIFT mass spectrometry and western blot analysis.
Main Results:
- Significant protein level changes were observed compared to T0 samples.
- Calpain11 showed a notable increase in the early PMI (<24 h).
- Caspases 7 and 8, along with Gasdermin 3, increased significantly in the late PMI (>24 h).
Conclusions:
- The identified proteins (Calpain11, Caspases 7/8, Gasdermin 3) show potential as biomarkers for different PMIs.
- These findings suggest a proteomic approach can aid in refining PMI estimation.
- Further investigation in diverse biological samples is warranted to confirm biomarker utility.


